Combination therapy for the treatment of migraine

Details Combination therapy for the treatment of migraine Combination therapy for the treatment of migraine

A - Human Necessities

61

K

A61K 31/522 (2006.01) A61K 31/341 (2006.01) A61K 31/404 (2006.01) A61K 31/4045 (2006.01) A61K 31/405 (2006.01) A61K 31/41 (2006.01) A61K 31/4178 (2006.01) A61K 31/4184 (2006.01) A61K 31/4196 (2006.01) A61K 31/42 (2006.01) A61K 31/422 (2006.01) A61K 31/427 (2006.01) A61K 31/433 (2006.01) A61K 31/44 (2006.01) A61K 31/4439 (2006.01) A61K 31/454 (2006.01) A61K 31/4725 (2006.01) A61K 31/495 (2006.01) A61K 45/00 (2006.01) A61K 45/06 (2006.01) A61P 25/06 (2006.01) C12N 9/99 (2006.01)

Patent

CA 2312989

Disclosed is a pharmaceutical composition for treating migraine in a mammal, including a human, which comprises a 5HT1, receptor agonist in combination with caffeine and a cyclooxygenase-2 (COX-2) inhibitor. Examples of the 5HT1 receptor agonist are eletriptan, rizatriptan, naratriptan, sumatriptan, zolmitriptan and ergotamine.

Affiliated with

Also associated with

Rating

Combination therapy for the treatment of migraine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy for the treatment of migraine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for the treatment of migraine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1696077